What the Most Famous Book About Trauma Gets Wrong
Read More »Tag: psilocybin
Psychedelic Drugs Are Rushing Towards Approval for Therapy. Here’s What’s Next
Psychedelic Drugs Are Rushing Towards Approval for Therapy. Here’s What’s Next
Yet one glaring problem remains. Despite promising clinical results, no one knows exactly how psychedelic drugs work in the brain. Examining their actions on brain cells isn’t just an academic curiosity. It could give rise to variants that maintain antidepressant properties without the high. And because hallucinogens substantially alter our perception [management?!] of the world, they could be powerful tools for investigating the neurobiology behind consciousness.
…
This year, scientists found another common theme—psychedelics seem to “reset” the brain to a more youthful state, at least in mice. Like humans, mice have an adolescent critical period, during which their brains are highly malleable and can easily rewire neural circuits, but the window closes after adulthood.
…
An earlier study showed that MDMA reopens the critical window in adult mice, so that they change their “personality.” Mice raised alone are often introverted and prefer to keep to themselves in adulthood. A dose of MDMA increased their willingness to snuggle with other mice—essentially, they learned to associate socializing with happiness, concluded the study.
It’s not that surprising. MDMA is well-known to promote empathy and bonding. The new study, by the same team, extended their early results to four psychedelics that don’t trigger fuzzy feelings—LSD, ketamine, psilocybin, and ibogaine. Similar to MDMA, adult mice raised alone changed their usual preference for solitude when treated with any of the drugs. Because habits are hard to change in adulthood—for mice and men—the drugs may have reopened the critical period, allowing the brain to more easily rewire neural connections based on new experiences.
…
These are just early results. But psychedelic research is gaining a new ally—artificial intelligence. Algorithms that predict protein structure, combined with rational drug design, could generate psychedelics that retain their psychiatric benefits without the high.
H/T: The Most Revolutionary Act
Related:
Psychoanalytic roots of CIA psychoprofiling/pseudoscience
Meaghan thought psychedelic therapy could help her PTSD. Instead it was the start of a nightmare
Why is the American right suddenly so interested in psychedelic drugs
What if a Pill Can Change Your Politics or Religious Beliefs? (archived)
Do Psychedelic Trips Change Your Political Views? (archived)
Dan Crenshaw’s measure greenlighting psychedelics to treat PTSD part of defense bill + More
The legislation would allow supervised clinical studies with active-duty members.
Dan Crenshaw’s measure greenlighting psychedelics to treat PTSD part of defense bill
Related:
First-ever provision for psychedelic studies included in defense bill
National Defense Authorization Act, pp. 402-406, p. 1817 ($50,311 allocated for R&D)
FDA Weighs New Application To Approve MDMA As First-Ever Psychedelic Medicine For PTSD + More About MAPS
A psychedelics-focused drug development company is officially asking the Food and Drug Administration (FDA) to review an application to approve MDMA as a prescription medication for the treatment of post-traumatic stress disorder (PTSD).
The MAPS Public Benefit Corporation (MAPS PBC) announced on Tuesday that it submitted the new drug application (NDA) to FDA, requesting an expedited review given that the agency previously designated the psychedelic as a breakthrough therapy.
FDA Weighs New Application To Approve MDMA As First-Ever Psychedelic Medicine For PTSD
H/T: The Most Revolutionary Act
The MAPS Public Benefit Corporation is subsidiary of Multidisciplinary Association for Psychedelic Studies. MAPS was founded by Rick Doblin.*
Related:
Read More »DEA Admits ‘Racial, Ethnic and Class Prejudice’ Led To Drug Criminalization And The Agency’s Own Founding
The Drug Enforcement Administration (DEA) is acknowledging the fact that racially discriminatory drug laws are partly responsible for the agency’s own founding.
DEA Admits ‘Racial, Ethnic and Class Prejudice’ Led To Drug Criminalization And The Agency’s Own Founding
How the CIA Illegally Used African Americans for Experimental Drug Research
By now, many will be familiar with Project MKULTRA. For decades, the CIA conducted highly unethical experiments on humans in order to perfect brainwashing, mind control and torture techniques.
Perhaps the program’s most notorious aspect was the administration of high doses of psychoactive drugs to targets, particularly LSD. These substances were brought to Langley’s attention in 1948 by Richard Kuhn, one of 1,600 Nazi scientists covertly spirited to the U.S. via Operation Paperclip following World War II. When MKULTRA was formally established five years later, some individuals consulted directly on the project.
How the CIA Illegally Used African Americans for Experimental Drug Research